Immunoconjugate Therapy of Hematologic Malignancies

Immunoconjugate Therapy of Hematologic Malignancies

Edited by  , Edited by 

Free delivery worldwide

Available. Dispatched from the UK in 4 business days
When will my order arrive?


The hybridoma technique for producing monoclonal antibodies developed by Drs. Kohler and Millstein in 1975 revolutionized the field of tumor immunology. It is now clear that there are antigens associated with or restricted to human neoplasms that have biologic significance. Monoclonal antibodies have already been demonstrated to have great immunodiagnostic value, and it is anticipated that they will become a component of our therapeutic armamentarium. Most investigators in the field, however, feel the true potential of monoclonal antibodies in cancer therapy remains to be determined. Clearly the most encouraging results have been witnessed in the treatment of hematologic malignancies. This volume of Cancer Treatment and Research explores the current state of the art of immunoconjugate therapy of hematologic malignancies. The first chapter, authored by Drs. Rosen and Kuzel, reviews the current status of radioimmunotherapy of lymphoma. Results of clinical investigations utilizing radiolabeled immunoconjugates in B-cell lymphomas, T-cell lym- phomas, and Hodgkin's disease are discussed. In addition, obstacles to effective antibody therapy are highlighted and toxicities are summarized.
Chapter 2, written by Drs. Sgouros and Scheinberg, critiques the treat- ment of leukemia with radiolabeled monoclonal antibodies. In this chapter, the unique features of leukemia that make it particularly suitable for radio- immunotherapy are discussed, an overview of selected clinical trials is presented, and a treatment planning approach to radioimmunotherapy in- corporating biologic and physical parameters is reviewed.
show more

Product details

  • Hardback | 205 pages
  • 155.96 x 233.93 x 14.22mm | 1,088.62g
  • Dordrecht, Netherlands
  • English
  • 1993 ed.
  • XIII, 205 p.
  • 0792322703
  • 9780792322702

Table of contents

1. Radioimmunotherapy of Lymphoma; T.M. Kuzel, S.T. Rosen. 2. High Dose Radioimmunotherapy of Lymphomas; O. Press, J. Eary, C. Badger, F. Applebaum, G. Wiseman, D. Matthews, P. Martin, I. Bernstein. 3. The Treatment of Leukemia with Radiolabeled Monoclonal Antibodies; G. Sgouros, D. Scheinberg. 4. New Approaches to Radiolabeling Monoclonal Antibodies; A.M. Zimmer, S. Spies. 5. Immunotoxin Therapy of Lymphoma; M. Grossbard, L. Nadler. 6. Immunotoxins for the Therapy of Graft vs Host Disease; D. Salzman, F. Lemaistre. 7. Recombinant Fusion Toxins - a New Class of Targeted Biologic Therapeutics; T. Woodworth, J. Nichols. 8. Chimeric Antibodies for the Treatment of Hematologic Malignancy; M. Dyer. 9. Immunoconjugate Therapy of Hematologic Malignancies; M. Fanger, P. Morganelli, P. Guyre. Index.
show more